RecruitingNCT05733104

A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea

Prospective Observational Post Marketing Surveillance Study to Observe Safety and Effectiveness of Zavicefta IV

Sponsor

Pfizer

Enrollment

600 participants

Start Date

Feb 19, 2024

Study Type

OBSERVATIONAL

Conditions

Complicated Intra-abdominal Infection Complicated urinary tract infection Hospital-Acquired Pneumonia

Summary

The purpose of this study is to learn about the safety and effectiveness of Zavicefta once released into the markets in Korea. This study is to learn about Zavicefta in patients with difficult types of infections in the abdomen, urinary tract and pneumonia which could have come from hospitalizations. This study was required by the Ministry of Food and Drug Safety (MFDS) of Korea's regulations.

Eligibility

Min Age: 3 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with complicated intra-abdominal infection, complicated urinary tract infection, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.